Here’s what you should know.
1. Allegan settled with Pennington, N.J.-based Zydus Pharmaceuticals and Ahmedabad, India-based Cadila Healthcare.
2. If approved by the FDA, Zydus and Cadila could market generic versions of Delzicol in the United States beginning March 1, 2020.
3. No details regarding the statement were available.
4. Allergan’s stocks opened at $190.40 on Dec. 2, 2016 and closed at $189.71. At noon on Dec. 5, 2016 the stock was up to $190.24.
More articles on gastroenterology/endoscopy news:
AGA Patient INFO Center integrates with gMed: 3 notes
Allergan’s GI business grows by 8.2% in Q3 & more — 3 GI company key notes
Valeant, Takeda deal crumbles; Valeant to invest in Salix: 6 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
